Business NewsPR NewsWire • Mayne Pharma launches BAC 300 capsules in the United States

Mayne Pharma launches BAC 300 capsules in the United States

Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg in the United States. Mayne Pharma received approval from the US Food and Drug Administration...

View More : https://www.prnewswire.com:443/news-releases/mayne-pharma-launches-bac-300-capsules-in-the-united-states-301064172.html
Releted News by prnewswire
ONEC Logistics Partners With IBS Software for LNG Project in Northwest British Columbia
Hikma receives FDA approval for its generic Vascepa®
Mayne Pharma launches BAC 300 capsules in the United States
Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport
Vermilion Energy Inc. Announces CEO Departure and the Appointments of Executive Chairman and President